Cargando…
MOBT Alleviates Pulmonary Fibrosis through an lncITPF–hnRNP-l-Complex-Mediated Signaling Pathway
Pulmonary fibrosis is characterized by the destruction of alveolar architecture and the irreversible scarring of lung parenchyma, with few therapeutic options and effective therapeutic drugs. Here, we demonstrate the anti-pulmonary fibrosis of 3-(4-methoxyphenyl)-4-oxo-4H-1-benzopyran-7-yl(αS)-α,3,4...
Autores principales: | Xu, Pan, Zhang, Haitong, Li, Huangting, Liu, Bo, Li, Rongrong, Zhang, Jinjin, Song, Xiaodong, Lv, Changjun, Li, Hongbo, Chen, Mingwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414852/ https://www.ncbi.nlm.nih.gov/pubmed/36014574 http://dx.doi.org/10.3390/molecules27165336 |
Ejemplares similares
-
Astaxanthin attenuates pulmonary fibrosis through lncITPF and mitochondria‐mediated signal pathways
por: Chen, Hongbin, et al.
Publicado: (2020) -
Paralogs hnRNP L and hnRNP LL Exhibit Overlapping but Distinct RNA Binding Constraints
por: Smith, Sarah A., et al.
Publicado: (2013) -
hnRNP A1 and hnRNP F Modulate the Alternative Splicing of Exon 11 of the Insulin Receptor Gene
por: Talukdar, Indrani, et al.
Publicado: (2011) -
HnRNP L represses cryptic exons
por: McClory, Sean P., et al.
Publicado: (2018) -
HnRNP Pathologies in Frontotemporal Lobar Degeneration
por: Jiang, Xinwa, et al.
Publicado: (2023)